Loading clinical trials...
Loading clinical trials...
The main objective of this study is to identify epigenetic markers specific to abnormal myeloid cells in patients with acute myeloid leukemia (AML) by analyzing the methylation of circulating cell-fre...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Collaborators
NCT07016165 · Neutropenic Fever, Acute Lymphoblastic Leukemia, and more
NCT05499611 · Acute Myeloblastic Leukemia
NCT01822015 · Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), and more
NCT01611116 · Acute Myeloblastic Leukemia
NCT00352365 · Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, and more
Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
Mulhouse, Alsace
GHRMSA
Mulhouse
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions